Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05755165 · ClinicalTrials.gov registry record · NA
Adolescent Depression: Video Ads on Instagram
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,235
- Enrollment target
NCT05755165 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,235 participants.
The verdict
NCT05755165, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,235 participants
- Enrollment target
Study Summary
The purposes of this study are to test among adolescent viewers the utility of different types of selfie short video-based messaging to: 1. Reduce stigma and self-stigma related to depression, and 2. Increase treatment-seeking intentions.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Depression
- BEHAVIORAL Depression, adjusted
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,235 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2024-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05755165
The ClinicalTrials.gov registry entry for NCT05755165 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT05755165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05755165 about?
NCT05755165 is a clinical study titled "Adolescent Depression: Video Ads on Instagram". The purposes of this study are to test among adolescent viewers the utility of different types of selfie short video-based messaging to: 1. Reduce stigma and self-stigma related to depression, and 2. Increase treatment-seeking intentions.
What is the current status of trial NCT05755165?
This trial is currently completed. It is a NA study. The enrollment target is 1,235 participants. The study started on 2024-08-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT05755165?
The interventions under investigation include: Control (BEHAVIORAL), Depression (BEHAVIORAL), Depression, adjusted (BEHAVIORAL).
Who is sponsoring clinical trial NCT05755165?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.